GlassScriptPhysician profile
Brandon Alan Guenthart
NPI 1700142858
$15,866.43
in general payments reported to CMS, 2019-2025
10 companies · $586 in 2025
The $586 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,734 · 2020: $296 · 2021: $3,208 · 2022: $6,741 · 2023: $555 · 2024: $2,746 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,819 · Food and Beverage: $1,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,818.76 |
| Food and Beverage | $1,068.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Transmedics, INC. | $7,241.60 | 2021-2024 | Organ Care System |
| Intuitive Surgical, INC. | $5,017.26 | 2019-2022 | |
| Abbott Laboratories | $2,060.14 | 2020-2022 | |
| Kls-Martin L.P. | $476.61 | 2021-2025 | |
| Atricure, INC. | $468.28 | 2024-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Paragonix Technologies, INC. | $282.35 | 2024 | Sherpapak, Pancreaspak, Baroguard |
| Davol INC. | $141.36 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $123.15 | 2025 | |
| Livanova USA, INC. | $41.00 | 2021 | |
| Medtronic Vascular, INC. | $14.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Guenthart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.